维普中文期刊产品整合服务
22篇 您的检索式:作者名="Sirima"
    题名 作者 年代 出处 被引量
1Micro-encapsulation of Pacific white shrimp oil as affected by emulsification condition显示文摘Micro-encapsulation of shrimp oil using the mixture of whey protein concentrate(WPC)and sodium caseinate(SC)(1:1,w/w)as a wall material was carried out.The impact of core/wall material ratios(1:2 and 1:4,w/w)and homogenizing pressures(13.79 and 27.58 MPa)on characteristics and stability of emulsion was investigated.The size of emulsion oil droplets decreased with increasing homogenizing pressure(P<0.05)but was not influenced by core/wall material ratio(P>0.05).During the extended storage,particle size,flocculation factor(Ff)and coalescence index(Ci)of all emulsions sharply increased,especially in emulsions prepared at 13.79 MPa with a core/wall material ratio of 1:2(P<0.05).After spray drying,micro-encapsulated shrimp oil(MSO)prepared at 13.79 MPa with a core/wall material ratio of 1:2 had the larger size than others(P<0.05).MSO prepared using a core/wall material ratio of 1:4 with homogenizing pressure of 27.58 MPa exhibited higher encapsulation efficiency(EE)(51.3%–52.8%)than others.Thus,both core/wall material ratio and homogenizing pressure directly affected micro-encapsulation of shrimp oil.Sirima Takeungwongtrakul Soottawat Benjakul Aran H-kittikun 2014Food Science and Human Wellness2014,3,3:5
22010-2015年全球实验室网络支持的消除麻疹和风疹工作的进展显示文摘2012年,世界卫生大会(World Health Assembly)签署全球疫苗行动计划(Global Vaccine Action Plan,GVAP),该计划旨在2020年前消除世界卫生组织(World Health Qrganization,WHO)5个区域的麻疹和风疹。2013年9月,WHO 6个区域的所有国家都已确立消除麻疹的目标,其中3个区域还确立了消除风疹和先天性风疹综合征的目标.mick n.mulders paul a.rota joseph p.icenogle kevin e.brown makoto takeda gloria j.rey myriam c.ben mamou annick r.g.a.dosseh charles r.byabamazima hinda j.ahmed sirima pattamadilok yan zhang marta gacic-dobo peter m.strebel james l.goodson 周惠嘉(翻译) 2018上海预防医学2018,30,2:4
3Cleaner gasoline production by using glycerol as fuel extender显示文摘Worapon Kiatkittipong Sirima Suwanmanee Navadol Laosiripojana Piyasan Praserthdam Suttichai Assabumrungrat 2009Fuel Processing Technology2009,,5:1
4Bioactive components of tea: Cancer, in- flammation and behavior显示文摘Elvira Gonzalez de Mejia Marco Vinicio Ramirez-Mares Sirima Puangpraphant 2009Brain Behavior and Immunity2009,23,6:1
5Prevalence of intestinal opportunistic parasites infections in the University hospital of Bobo-Dioulasso, Burkina Faso显示文摘Background:Gastrointestinal parasites infections are widespread in Africa and their prevalence infections vary from country to country.This study aimed at assessing the prevalence of opportunistic intestinal parasites infection and other gastrointestinal parasites infection among patients attending the laboratory of Parasitology and Mycology of the University Hospital Souro Sanou of Bobo-Dioulasso.Methods:A hospital cross-sectional based study was conducted from April to August,2012.Participants were persons whom parasitological examination of stools has been prescribed by a clinician.The stools examination methods included direct wet saline examination,lugol’s iodine staining technique,formol-ether concentration and modified Ziehl-Neelsen staining.We recorded age and sex information for each patient.Results:The overall prevalence of intestinal parasite infections was 65.3%(190/291).Majority of the parasitic infections was waterborne(64.3%)consisting of high prevalence of Cryptosporidium sp.(26.5%)and Entamoeba histolytica/dispar(23.4%).The prevalence of opportunistic parasites was 28.9%and Cryptosporidium sp.was the most prevalent species followed by Blastocystis sp.(1.0%),Cyclospora sp.(0.7%)and Isospora belli(0.7%).The prevalence of intestinal helminthes was 1.7%.Conclusions:The prevalence of intestinal parasitism in general remains high in Bobo-Dioulasso requiring the establishment of adequate diagnostic techniques,treatment and prevention.Ibrahim Sangaré Sanata Bamba Mamoudou Cissé Adama Zida Rabila Bamogo Constant Sirima Bienvenue KYaméogo Roger Sanou François Drabo Roch KDabiré Robert TGuiguemdé 2015Infectious Diseases of Poverty2015,4,1:1
6Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy,semi-immune adult males in Burkina Faso,West Africa显示文摘Sirima SB Nebie I Ouedraogo A 2007Vaccine2007,25,14:1
7Haemoglobin C protects against clinical Plasmodium falciparum malaria显示文摘Modiano D Luoni G Sirima BS 2001Nature2001,414,6861:1
8Development and evaluation of gastro- retentive raft forming systems incorporating cureumin - Eu- dragit EPO solid dispersions forgastric ulcer treatment显示文摘Nattha Kerdsakundee Sirima Mahattanadul Ruedeekorn Wiwattanapatapee 2015European Journal of Pharmaceutics and Biopharmaceutics2015,94,10:1
9Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin,and absorption studies in rats显示文摘Saipin Setthacheewakul Sirima Mahattanadul Narubodee Phadoongsombut 2010Eur J Pharm Biopharm2010,76,:1
10Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa 显示文摘Sirima Sodiomon B Nebie I Ouedraogo A 2007Vaccine2007,25,14:1
11The in uence of storage conditions of tuna viscera before fermentation on the chemical, physical and microbiological changes in fish sauce during fermentation 显示文摘Sirima Dissaraphong Soottawat Benjakul Wonnop Vises- sanguan 2006Bioresource Technology2006,97,:1
12Different response to Plasmodium falciparum malaria in West African sympatric ethnic groups显示文摘Modiano D Petrarca V Sirima B S 1996Proc Natl Acad Sci USA1996,93,13:1
13The lower susceptibility to Plasmodium falciparum malaria of Fulani of Burkina Faso(West Africa) is associated with low frequencies of classic malaria-resistance genes显示文摘Modiano D Luoni G Sirima B S 2001Trans R Soc Trop Med Hyg2001,95,:1
14Artesunate-amodiaquine for the treatment of uncomplicated malaria显示文摘Sirima SB Gansan A 2007Expert Opin Investig Drugs2007,16,7:1
15Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa显示文摘Sirima SB Nebie I Ouedraogo A 2007Vaccine2007,25,14:1
16Safety and im- munogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children显示文摘Sirima SB Tiono AB Ourdraogo A 2009PLoS One2009,4,10:1
17Protection against malaria by MSP3 candidate vaccine显示文摘Sirima SB Cousens S Druilhe P 2011N Engl J Med2011,365,11:1
18Esterification of oleic acid and high acid content palm oil over anacid-activa- ted bentonite catalyst显示文摘SIRIMA J DUANGAMOL N T 2014Applied Clay Science2014,87,:1
19Protection against malaria by MSP3 candidate vaccine 显示文摘Sirima SB Cousens S Druilhe P 2011N Engl J Med2011,365,11:1
20Haemoglobin C protects against clinical Plasmodium falciparum malaria 显示文摘Modiano D Luoni G Sirima BS 2001Nature2001,414,6861:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费